Skip to main content
. 2017 Nov 22;1(25):2386–2391. doi: 10.1182/bloodadvances.2017009514

Table 3.

Results of thrombophilia testing during the acute phase

Number of tests ordered during the acute phase Number of positive tests during the acute phase (% positivity) Number of positive tests repeated (% repeated) Number of confirmed positive tests* Number of potential false-positive diagnoses
FVL 34 3 (9) 0
Prothrombin gene mutation 34 0 (0) 0
AT 34 6 (18) 4 (67) 0 2
PC 33 3 (9) 3 (100) 0 0
PS 33 9 (28) 5 (56) 1 4
LA 42 12 (29) 9 (75) 1 3
Anticardiolipin 44 1 (2) 0 (0) 0 1
aβ2GPI 43 7 (16) 4 (57) 1 3
Antiphosphatidylserine 30 2 (7) 0 (0) 0 2
Total 327 43 (13) 25 (63) 3 15
*

Requires a persistently positive repeat test ≥12 wk apart or a single positive PCR assay.

All heterozygous.

The percentage of positive tests repeated excludes the 3 positive FVL PCR assays.